Literature DB >> 9831342

An unusual fragile X sibship: female compound heterozygote and male with a partially methylated full mutation.

S Russo1, V Briscioli, F Cogliati, M Macchi, F Lalatta, L Larizza.   

Abstract

We describe here a fragile X sibship of borderline retarded sister and brother born to carrier parents. The sister is a compound heterozygote (with a full mutation on one X chromosome and a pre-mutation on the other X chromosome). The brother has a partially methylated full mutation. The activation ratio (AR) for the sister's pre-mutation was 0.69 and the percent lack of methylation for the brother's full mutation was 73%. Intellectual and neuropsychological Wechsler Adult Intelligence Scale (W.A.I.S.) achievement tests reported full scale IQ scores of 74 in the sister and 77 in the brother. A significant discrepancy between verbal and performance IQ was found in the sister, indicating that her main impairment was in the cognitive area. The parents of this unusual sibship came from a small village, as did one of the two previously described cases of compound heterozygous females. These rare females raise special issues for genetic counselling in fragile X carrier couples, the frequency of which remains to be defined in different populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831342     DOI: 10.1034/j.1399-0004.1998.5440408.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Authors:  Edda Haberlandt; Sibylle Zotter; Martina Witsch-Baumgartner; Johannes Zschocke; Dieter Kotzot
Journal:  Eur J Pediatr       Date:  2014-07-17       Impact factor: 3.183

2.  A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male.

Authors:  Page L Sorensen; Kirin Basuta; Guadalupe Mendoza-Morales; Louise W Gane; Andrea Schneider; Randi Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.